BRIXADI (WEEKLY DOSING) J Code: J0577
Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
Drug & Product Overview
About BRIXADI (WEEKLY DOSING)
Brixadi (weekly Dosing) is a medication aligned to the HCPCS J Code: J0577 for billing, pricing, and reimbursement purposes in the United States. It is an Anti-Addiction drug administered via the subcutaneous route and manufactured by Braeburn Pharmaceutical.
According to CMS Drug Use Information: Buprenorphine is used to treat opioid use disorder. This long-acting form of buprenorphine should be used after starting treatment with a single dose of a transmucosal form of buprenorphine (one that is used under the tongue or inside the cheek) or after being treated with buprenorphine. Buprenorphine belongs to a class of drugs known as mixed opioid agonist-antagonists. It helps prevent withdrawal symptoms caused by stopping other opioids. It is used as part of a complete treatment program for opioid use disorder (such as compliance monitoring, counseling, behavioral contract, lifestyle changes).
Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.
NDC Code Information
Based on publicly available CMS files. The list of NDCs below is not exhaustive.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| 58284-0208-01 | Brixadi | Braeburn Inc. | 1 | 8 MG / 0.16 ML |
| 58284-0216-01 | Brixadi | Braeburn Inc. | 1 | 16 MG / 0.32 ML |
| 58284-0224-01 | Brixadi | Braeburn Inc. | 1 | 24 MG / 0.48 ML |
| 58284-0232-01 | Brixadi | Braeburn Inc. | 1 | 32 MG / 0.64 ML |
BRIXADI (WEEKLY DOSING) Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →
Historical Graphing and Billing Calculator
Log in to calculate billing and reimbursement with live ASP, WAC & AWP pricing.
Login to use the calculator →Buprenorphine Extended-release 505(b)(2) Information:
| HCPCS Code | Manufacturer | Active Ingredient | HCPCS Description |
|---|---|---|---|
| J0577 | Braeburn Pharmaceutical | Buprenorphine Extended-release | Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy |
| J0578 | Braeburn Pharmaceutical | Buprenorphine Extended-release | Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy |
| Q9991 | Indivior | Buprenorphine Extended-release | Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg |
| Q9992 | Indivior | Buprenorphine Extended-release | Injection, buprenorphine extended-release (sublocade), greater than 100 mg |
BRIXADI (WEEKLY DOSING) CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96372 | Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular |
This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →
BRIXADI (WEEKLY DOSING) Medically Unlikely Edits (MUE)
The most billing units of J0577 Medicare will pay for one patient in one day, as published by CMS. 1 unit = less than or equal to 7 days of therapy.
MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →
BRIXADI (WEEKLY DOSING) Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is a Brixadi (Weekly Dosing) billing and coding guide available?
Is Brixadi (Weekly Dosing) patient assistance information available?
Where can I find Brixadi (Weekly Dosing) prescribing information?
Where can I find Brixadi (Weekly Dosing) side effect information?
Does billing BRIXADI (WEEKLY DOSING) require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to BRIXADI (WEEKLY DOSING).
